Integrated bioinformatics and single-cell analysis identifies vascular aging-related hub genes and immune drivers in atherosclerosis.

By integrating bulk and single-cell transcriptomic analyses, this study identifies seven vascular aging-related hub genes (including TNF, MMP9, and APOE) as key diagnostic biomarkers and immune drivers in atherosclerosis, while proposing curcumin as a potential therapeutic agent targeting these genes.

The Gist

Imagine your body's blood vessels as a vast network of highways that deliver oxygen and nutrients to every city block (organ) in your body. Over time, just like real roads, these highways get worn down. This wear and tear is called vascular aging. When the road surface gets rough and the guardrails weaken, it becomes easy for "traffic jams" to form. In the body, these jams are atherosclerosis (plaque buildup), which can lead to heart attacks or strokes.

For a long time, doctors knew aging and heart disease were linked, but they didn't know exactly which construction crews were causing the damage or how to fix the specific potholes.

This study is like a team of digital detectives and biological mechanics who decided to solve this mystery by looking at the blueprints of the city (genetic data) and then testing their theories in a real lab.

Here is the story of their investigation, broken down into simple steps:

1. The Digital Detective Work (Bioinformatics)

The researchers started by gathering old case files from a massive digital library (called GEO). They looked at two huge piles of data:

• Pile A: Genes from healthy arteries.
• Pile B: Genes from arteries clogged with plaque.

They also had a "Wanted Poster" list of genes known to be involved in aging. They used a computer program to cross-reference these lists, looking for the specific genes that were both "aging-related" and "clogged-up."

The Result: They found 28 suspects. These were the genes acting up in the aging, clogged arteries.

2. Finding the Masterminds (Hub Genes)

Out of the 28 suspects, the researchers needed to find the ringleaders. They built a digital map showing how these genes talked to each other (like a social network). They found that a few genes were the "influencers" connected to everyone else.

They narrowed it down to 7 Masterminds:

1. MMP9 (The Demolition Crew)
2. APOE (The Trash Collector)
3. TNF (The Alarm Siren)
4. ICAM1 (The Gatekeeper)
5. PPARG (The Traffic Manager)
6. CYBA & NCF2 (The Oxidative Stress Generators)

3. The Real-World Check (Lab Validation)

Computers are great, but you can't trust them without a reality check. The researchers went to the lab and used mice. They fed some mice a "junk food" diet to make their arteries clog up, while others ate healthy food.

They took samples and ran a test (qRT-PCR) to see if the 7 Masterminds were actually louder (more active) in the sick mice. Bingo! The genes were screaming much louder in the clogged arteries. This confirmed the computer's guess was right.

4. The Diagnostic Test (ROC Analysis)

The researchers asked: "If we just look at the volume of these 7 genes, can we tell if a patient has heart disease?"
They ran a diagnostic test (like a lie detector for genes).

• TNF was the best detective, with a very high accuracy score.
• Most of the others were also good at spotting the disease.
  This means these genes could become early warning signs for doctors to catch heart disease before a heart attack happens.

5. Who is Doing the Damage? (Immune Cells & Single-Cell Analysis)

The researchers wanted to know where these genes were coming from. They used a high-tech microscope (single-cell RNA sequencing) to look at individual cells in the arteries.

They found that the trouble was mostly coming from two types of "security guards" (immune cells):

• Monocytes: The heavy-duty cleanup crew that often gets stuck and causes inflammation.
• T-Cells: The specialized soldiers that patrol the area.

The Big Discovery: The gene TNF (the Alarm Siren) was blasting its signal specifically inside the T-Cells. This suggests that the T-cells are the ones turning up the heat, causing chronic inflammation that ages the blood vessels and builds the plaque.

6. The Natural Remedy (Curcumin)

Finally, the team asked: "Is there anything we can use to shut down these alarm sirens?"
They looked at Curcumin (the bright yellow spice in turmeric), which is famous for being anti-inflammatory. They used a computer simulation (molecular docking) to see if Curcumin could physically lock onto these 7 Mastermind genes and stop them from working.

The Result: Curcumin fit perfectly into the "locks" of these genes, especially PPARG (the Traffic Manager). It's like finding a key that fits the ignition of the engine causing the traffic jam. This suggests that turmeric (or drugs based on it) might be able to calm down the aging process in our arteries.

The Takeaway

This study connects the dots between getting old and heart disease. It tells us that as we age, our immune system (specifically T-cells and Monocytes) starts screaming inflammatory alarms (TNF), which damages our blood vessels.

Why does this matter?

1. New Tests: Doctors might soon use these 7 genes to predict heart disease earlier.
2. New Treatments: We might be able to target these specific genes to stop the aging process in our arteries.
3. Dietary Hope: It gives a scientific "green light" to the idea that natural anti-inflammatories like curcumin could help protect our hearts by quieting these specific genetic alarms.

In short: The researchers found the specific "bad actors" in our aging arteries and found a potential "key" (Curcumin) to lock them up, offering new hope for keeping our internal highways smooth and clear.

Technical Summary

1. Problem Statement

Atherosclerosis (AS) is a chronic inflammatory disease and the leading cause of cardiovascular death. While traditional risk factors (hypertension, diabetes, etc.) are well-known, the specific molecular mechanisms linking vascular aging to AS pathogenesis remain incompletely understood. Vascular aging involves cellular senescence and the Senescence-Associated Secretory Phenotype (SASP), which drives inflammation and plaque instability. There is a critical need to identify:

• Specific genes that are both differentially expressed in AS and related to vascular aging (VARDEGs).
• The key "hub" genes driving these processes.
• The immune cell subsets responsible for these interactions.
• Potential therapeutic targets, specifically natural compounds that could modulate these aging-related pathways.

2. Methodology

The study employed a multi-step integrated approach combining bulk transcriptomics, single-cell RNA sequencing (scRNA-seq), experimental validation, and computational modeling:

• Data Acquisition & Integration:
  • Downloaded bulk microarray datasets GSE100927 and GSE43292 from GEO (human arterial tissue).
  • Retrieved 69 Vascular Aging-Related Genes (VARGs) from the GeneCards database.
  • Used the sva R package to remove batch effects and merged the datasets (101 AS samples, 67 controls).
• Differential Expression & Screening:
  • Identified Differentially Expressed Genes (DEGs) using limma (threshold: $|logFC| > 0.25$, $adj. P < 0.05$).
  • Intersected DEGs with VARGs to obtain 28 VARDEGs.
• Functional & Network Analysis:
  • Performed GO and KEGG enrichment analyses to determine biological processes and pathways.
  • Conducted Gene Set Enrichment Analysis (GSEA) on the combined dataset.
  • Constructed a Protein-Protein Interaction (PPI) network using the STRING database ($score > 0.7$).
  • Screened for Hub Genes using five CytoHubba algorithms (MCC, Degree, MNC, EPC, Closeness) and identified the intersection.
  • Constructed Transcription Factor (TF) and miRNA regulatory networks using ChIPBase and TarBase databases.
• Immune & Single-Cell Analysis:
  • Performed ssGSEA to quantify 28 immune cell types and correlate them with hub genes.
  • Analyzed scRNA-seq data (GSE184073) using Seurat and SingleR to map hub gene expression to specific cell clusters (T cells, monocytes, B cells, NK cells).
• Experimental Validation:
  • qRT-PCR: Validulated the expression of 7 hub genes in ApoE-/- mice (AS model vs. control) fed a high-fat diet.
  • ROC Analysis: Evaluated diagnostic accuracy of hub genes using the combined GEO datasets.
• Therapeutic Exploration:
  • Performed Molecular Docking (AutoDock Vina) to assess the binding affinity of Curcumin to the identified hub genes.

3. Key Contributions

• Identification of VARDEGs: Successfully identified 28 genes that are differentially expressed in AS and specifically linked to vascular aging.
• Hub Gene Discovery: Narrowed down the list to 7 critical hub genes: MMP9, APOE, TNF, ICAM1, PPARG, CYBA, and NCF2.
• Immune Cell Localization: Utilized scRNA-seq to pinpoint that these hub genes are predominantly expressed in Monocytes and T cells, with TNF showing specific overexpression in T cells, identifying them as key immune drivers.
• Therapeutic Mechanism: Provided a computational basis for the use of Curcumin as a therapeutic agent, demonstrating strong binding affinity to these aging-related hubs, particularly PPARG.

4. Key Results

• Gene Identification: 28 VARDEGs were identified. Functional enrichment highlighted roles in muscle cell proliferation, lipid metabolism, NADPH oxidase activity, and pathways like IL-12, PI3K-Akt, NF-κB, and JAK-STAT.
• Hub Gene Validation:
  • The 7 hub genes were significantly upregulated in AS samples compared to controls in both the GEO datasets and the mouse model (qRT-PCR).
  • ROC Analysis: Six of the hub genes (MMP9, APOE, TNF, PPARG, CYBA, NCF2) showed moderate-to-high diagnostic accuracy ($0.7 < AUC < 0.9$). TNF exhibited the highest performance. ICAM1 showed lower accuracy ($0.5 < AUC < 0.7$).
• Immune Correlation:
  • Significant alterations were found in 28 immune cell types, with strong correlations between hub genes and monocytes and T cells.
  • NCF2 showed the strongest positive correlation with activated dendritic cells.
• Single-Cell Insights:
  • In the scRNA-seq dataset, T cells constituted the largest subpopulation, followed by monocytes.
  • Core genes were predominantly localized to these two cell types, reinforcing the "inflamm-aging" hypothesis where T-cell derived TNF drives disease progression.
• Molecular Docking:
  • Curcumin demonstrated strong binding affinity (binding energy $< -5$ kcal/mol) to all six tested hub genes.
  • The strongest interaction was observed with PPARG, suggesting a mechanism where curcumin modulates lipid metabolism and inflammation via this receptor.

5. Significance

• Mechanistic Insight: The study elucidates the molecular crosstalk between vascular aging and atherosclerosis, confirming that cellular senescence drives AS through specific immune-mediated inflammatory pathways (SASP).
• Diagnostic Potential: The identified hub genes, particularly TNF, MMP9, and PPARG, serve as potential biomarkers for the early diagnosis and risk stratification of atherosclerosis.
• Therapeutic Targeting: By identifying PPARG and TNF as key drivers and validating Curcumin's binding affinity, the study proposes a novel therapeutic strategy involving natural compounds to target vascular aging and immune dysregulation.
• Future Direction: The findings bridge the gap between bulk transcriptomics and single-cell resolution, suggesting that targeting the monocyte-T cell axis and senescence-related pathways could be a viable strategy to delay atherosclerosis progression.

Limitations noted by authors: The experimental validation sample size was small; bioinformatics relied on public bulk data (though supplemented by scRNA-seq); molecular docking predictions require in vitro and in vivo verification; and spatial transcriptomics is needed to map these interactions within the plaque architecture.